[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338095-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338095-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","combining-radiomics-and-molecular-biomarkers-a-novel-economic-tool-to-improve-diagnostic-ability-in-papillary-thyroid-cancer","Combining radiomics and molecular biomarkers - a novel economic tool to improve diagnostic ability in papillary thyroid cancer","","Preoperative identification of malignant versus benign thyroid nodules requires accurate and sensitive methods, yet existing clinical approaches remain insufficient. This retrospective study develops an economic diagnostic strategy for an eastern population by combining radiomics with molecular biomarker analysis. ITK-SNAP and Ultrosomics generate radiomic features, while whole-transcriptome sequencing and bioinformatics nominate candidate genes and RT-qPCR validates expression. The final integrated C-thyroid model shows high performance in training and validation sets. The approach relies on four genes plus clinical data.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/combining-radiomics-and-molecular-biomarkers-a-novel-economic-tool-to-improve-diagnostic-ability-in-papillary-thyroid-cancer/338095/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/combining-radiomics-and-molecular-biomarkers-a-novel-economic-tool-to-improve-diagnostic-ability-in-papillary-thyroid-cancer/338095.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does this study address in thyroid nodule diagnosis?","Question",{"text":63,"@type":64},"The study targets the need for accurate, sensitive preoperative diagnosis to distinguish malignant from benign thyroid nodules, especially papillary thyroid cancer, since current clinical methods do not adequately solve this issue.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were radiomics and molecular biomarkers combined to build the diagnostic model?",{"text":68,"@type":64},"Radiomic features were extracted from regions of interest using ITK-SNAP and Ultrosomics, while whole-transcriptome sequencing and bioinformatics identified candidate genes that were evaluated by RT-qPCR. A molecular model was built from selected genes and clinical information, then integrated with the radiomic model and optimized as the final C-thyroid model.",{"name":70,"@type":61,"acceptedAnswer":71},"Which genes were ultimately selected for the final diagnostic panel?",{"text":72,"@type":64},"CLDN10, HMGA2, and LAMB3 were screened for model building, and the resulting integrated diagnostic panel was based on these genetic data together with partial clinical information.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338095,1790246135,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 14 August 2024  \nDOI 10.3389/fendo.2024.1378360  \nOPEN ACCESS  \nEDITED BY  \nClaudio Casella, University of Brescia, Italy  \nREVIEWED BY  \nMarina Muzza,  \nItalian Auxological Institute (IRCCS), Italy Jeehee Yoon,  \nChonnam National University Bitgoeul Hospital, Republic of Korea  \n*CORRESPONDENCE Chunjue Ni  \n [Cccrytial@163.com](Cccrytial@163.com)[ ](Cccrytial@163.com)Yefeng Cai  \n [cyfoncology@wmu.edu.cn](cyfoncology@wmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 29 January 2024  \nACCEPTED 10 June 2024  \nPUBLISHED 14 August 2024  \nCITATION  \nWang Q, Dai L, Lin S, Zhang S, Wen J, Chen E, Li Q, You J, Qu J, Ni C and Cai Y (2024) Combining radiomics and molecular biomarkers: a novel economic tool to improve diagnostic ability in papillary thyroid cancer.  \nFront. Endocrinol. 15:1378360 .  \ndoi: 10.3389/fendo.2024.1378360  \nCOPYRIGHT  \n© 2024 Wang, Dai, Lin, Zhang, Wen, Chen, Li, You, Qu, Ni and Cai. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCombining radiomics and molecular biomarkers: a novel economic tool to improve diagnostic ability in papillary thyroid cancer  \nQingxuan Wang1,2†, Linghui Dai 3†, Sisi Lin 4†, Shuwei Zhang 5, Jing Wen 1, Endong Chen 5, Quan Li 5, Jie You 1, Jinmiao Qu 1, Chunjue Ni 6* and Yefeng Cai 1,7*  \n1 Department of Thyroid Surgery, National Key Clinical Specialty (General Surgery), The First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China, 2Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Afﬁliated Hospital, Wenzhou Medical University, Wenzhou, China, 3 Division of thyroid Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Afﬁliated Hospital of Medical School, Nanjing University, Nanjing,  \nJiangsu, China, 4 Department of Operating Room, The First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China, 5 Department of Breast Surgery, The First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China, 6 Department of Anesthesiology, The First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China, 7Zhejiang Provincial Clinical Research Center for Malignant Tumor, Hangzhou, Zhejiang, China  \nBackground: A preoperative diagnosis to distinguish malignant from benign thyroid nodules accurately and sensitively is urgently important. However, existing clinical methods cannot solve this problem satisfactorily. The aim of this study is to establish a simple, economic approach for preoperative diagnosis in eastern population.  \nMethods: Our retrospective study included 86 patients with papillary thyroid cancer and 29 benign cases. The ITK-SNAP software was used to draw the outline of the area of interest (ROI), and Ultrosomics was used to extract radiomic features. Whole-transcriptome sequencing and bioinformatic analysis were used to identify candidate genes for thyroid nodule diagnosis. RT-qPCR was used to evaluate the expression levels of candidate genes. SVM diagnostic model was established based on the METLAB 2022 platform and LibSVM 3 .2 language package.  \nResults: The radiomic model was ﬁrst established. The accuracy is 73 . 0%, the sensitivity is 86 . 1%, the speciﬁcity is 17 . 6%, the PPV is 81 . 6%, and the NPV is 23 . 1% . Then, CLDN10, HMGA2, and LAMB3 were ﬁnally screened for model building. All three genes showed signiﬁcant differential expressions between papillary thyroid cancer and normal tissue both in our cohort and TCGA cohort. The molecular model was established based on these gene","cbCaiqJHFMZ21D9Z","https://ap.wps.com/l/cbCaiqJHFMZ21D9Z","pdf",4242045,"English","# Background\n# Methods\n# Results\n# Discussion\n# Keywords\n# Introduction","[{\"question\":\"What problem does this study address in thyroid nodule diagnosis?\",\"answer\":\"The study targets the need for accurate, sensitive preoperative diagnosis to distinguish malignant from benign thyroid nodules, especially papillary thyroid cancer, since current clinical methods do not adequately solve this issue.\"},{\"question\":\"How were radiomics and molecular biomarkers combined to build the diagnostic model?\",\"answer\":\"Radiomic features were extracted from regions of interest using ITK-SNAP and Ultrosomics, while whole-transcriptome sequencing and bioinformatics identified candidate genes that were evaluated by RT-qPCR. A molecular model was built from selected genes and clinical information, then integrated with the radiomic model and optimized as the final C-thyroid model.\"},{\"question\":\"Which genes were ultimately selected for the final diagnostic panel?\",\"answer\":\"CLDN10, HMGA2, and LAMB3 were screened for model building, and the resulting integrated diagnostic panel was based on these genetic data together with partial clinical information.\"}]","Combining radiomics and molecular biomarkers - a novel economic tool to improve diagnostic ability in papillary thyroid cancer | PDF",1790021931,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e3ae55c81935b2abf1939dc98ef5203.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6b33621b59a0e398584d58b22a678ec.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/758c76f122cf6da27e0f56ea4cd254f0.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fb78343173ca271c2ee2687ca50a6e6.webp",980,1385]